Rosa Lapalombella

13PUBLICATIONS
130CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 06, 2026
Enhancing tyrosine kinase inhibitor sensitivity by restoring IKAROS activity on GLUT1 expression and glycolysis in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Linyao Zhang, Qi Han, Huimin Xiang

|Nov 25, 2025
SINE compounds activate exportin 1 degradation through an allosteric mechanism.

Casey E Wing, Ho Yee Joyce Fung, Bert Kwanten

|Nov 05, 2025
PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor-Resistant Chronic Lymphocytic Leukemia.

Britten K Gordon, Elizabeth M Muhowski, Jyotsana Singh

|Aug 26, 2025
The Novel Immunocompetent Eµ-SOX11CCND1 Mouse Model Phenotypically and Molecularly Resembles Human Mantle Cell Lymphoma.

Hedieh Jafari, Fiona Brown-Burke, Betsy Pray

|Oct 17, 2024
SINE compounds activate exportin-1 degradation via an allosteric mechanism.

Casey Elizabeth Wing, Ho Yee Joyce Fung, Bert Kwanten

|Dec 27, 2023
Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal Hematopoiesis.

Caner Saygin, Pu Zhang, Jacob Stauber

Pageof 3

Frequent Collaborators

6 joint publications

James S Blachly

5 joint publications

Mehdi Gharghabi

5 joint publications

Dirk Daelemans

5 joint publications

Jennifer Woyach